Chelsea Therapeutics International, Ltd.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | −$236.2M | −$31.8M | −$188.0M | −$37.5M |
| Net income | −$231.5M | −$31.7M | −$183.3M | −$37.3M |
| Total assets | $46.5M | $28.9M | $46.9M | $48.4M |
| Total liabilities | $3.2M | $3.0M | $13.2M | $13.2M |
| Equity | $43.3M | $25.9M | $33.7M | $35.2M |
| EPS (diluted) | — | — | — | — |
| Shares out. | 67.1M | 67.0M | 62.0M | 49.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- —
- Net margin
- —
- Return on equity
- −535.1%
- Return on assets
- −497.8%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 7.0%
- Debt / equity
- 0.08×
- Book value / share
- $0.64
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Accruals / assets
- −35.5%clean
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 2 good- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJun 24, 2014
- Other material eventMay 12, 2014
- Entered a material agreement · Regulation FD disclosureMay 8, 2014
- Other material eventFeb 19, 2014
- Regulation FD disclosureFeb 14, 2014
- Director / officer changeJan 30, 2014
- Director / officer changeJan 27, 2014
- Other material eventNov 15, 2013
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GJul 3, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- EFFECTJun 26, 2014
- 4OWNERSHIP DOCUMENTJun 25, 2014
- 4OWNERSHIP DOCUMENTJun 25, 2014
- 4OWNERSHIP DOCUMENTJun 25, 2014
- 4OWNERSHIP DOCUMENTJun 25, 2014
- 4OWNERSHIP DOCUMENTJun 25, 2014
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.